ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Synthesis

Synthesis helps scientists create sufficient amounts of these polyphenols for biological studies

Resveratrol—made famous by its presence in red wine—has been touted for its health benefits. Oligomers of the compound may have even more

by Bethany Halford
December 19, 2016 | APPEARED IN VOLUME 94, ISSUE 49

Resveratrol—made famous by its presence in red wine—has been touted for its health benefits. Oligomers of the compound may have even more promising medicinal properties, as they exhibit anti-inflammatory, immunomodulatory, and cytotoxic activities in cell studies. But getting enough of these complex polyphenols to study their mechanisms of action has been challenging. Chemists led by the University of Michigan’s Corey Stephenson and the University of Ottawa’s Derek Pratt now report a stereoconvergent synthesis of the resveratrol tetramers nepalensinol B and vateriaphenol C in 13 steps (Science 2016, DOI: 10.1126/science.aaj1597). Their strategy makes use of a persistent radical (shown) that’s derived from the resveratrol dimer, ε-viniferin. “Persistent free radicals have become indispensable in the synthesis of organic materials through living radical polymerization,” the chemists point out in the report. “However, examples of their use in the synthesis of small molecules are rare.” Stephenson and Pratt note that thermodynamic stereocontrol in the dimerization of persistent free radicals plays a critical role in their strategy.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment